Background: Polymorphisms in DNA repair genes can alter an individual's DNA repair capability and contribute to the risk of various cancers. Aims: This study was designed to evaluate the association of single-nucleotide polymorphisms (SNPs) in the XPG gene with the risk of gastric cardia adenocarcinoma (GCA) in a high-incidence population in northern China. Methods: Two SNPs from 431 GCA patients and 432 healthy controls were genotyped using the polymerase chain reaction/ligase detection reaction (PCR-LDR) method. Results: The rs751402 C/T SNP T allele and the T/T genotype were associated with an increased risk of GCA in younger individuals (≤61 years) (odds ratio [OR] = 1.33 and 1.77, 95% confidence interval [CI] = 1.00-1.76 and 1.12-3.30, respectively). The rs873601 G/A SNP was not associated with susceptibility to GCA. Conclusions: Our findings indicate that the rs751402 C/T SNP has potential as a predictive marker for the risk of GCA and that carriers of the T/T genotype should receive periodic upper gastrointestinal fiber tests to facilitate the early detection and early treatment of GCA.
Get full access to this article
View all access options for this article.
References
1.
BesshoT (1999) Nucleotide excision repair 3′ endonuclease XPG stimulates the activity of base excision repairenzyme thymine glycol DNA glycosylase. Nucleic Acids Res, 27:979-983.
2.
CarthariusK, FrechK, GroteK, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics, 21:2933-2942.
3.
ChenJ, XieF, ChenK, et al. (2009) ERCC5 promoter polymorphisms at −763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer. Cancer Biol Ther, 8:1424-1430.
4.
ChenJF (2009) Detection and Functional Analysis of SNPs in the ERCC5 Promoter in Patients with Advanced Colorectal Cancer Treated with Platinum-Based Chemotherapy. Third Military Medical University, Chongqing.
5.
ChenZF, SongGH, HouJ, et al. (2011) Esophageal and gastric cancer incidence trend in Cixian from 1988 to 2007. Chin J Clin Oncol, 38:839-842.
6.
ChengL, EicherSA, GuoZ, et al. (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev, 7:465-468.
7.
ClarksonSG (2003) The XPG story. Biochimie, 85:1113-1121.
8.
CrawfordEL, BlomquistT, MullinsDN, et al. (2007) CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis, 28:2552-2559.
9.
DengN, LiuJW, SunLP, et al. (2014) Expression of XPG protein in the development, progression and prognosis of gastric cancer. PLoS One, 9:e108704.
10.
DuanZ, HeC, GongY, et al. (2012) Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene, 511:274-279.
11.
FieldingJWL, PowellJ, AllumWH (1989) Cancer of the Stomach. The Macmillan Press, London.
12.
GudmundssonJ, SulemP, ManolescuA, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet, 39:631-637.
13.
HaimanCA, PattersonN, FreedmanML, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet, 39:638-644.
14.
HeJ, QiuLX, WangMY, et al. (2012) Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet, 131:1235-1244.
15.
HuW, PanJ, ZhaoP, et al. (2014) Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer. Tumour Biol, 35:5561-5567.
16.
KamangarF, ChowWH, AbnetCC, et al. (2009) Environ-mental causes of esophageal cancer. Gastroenterol Clin North Am, 38:27-57.
17.
KiemeneyLA, ThorlaciusS, SulemP, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet, 40:1307-1312.
18.
KlunglandA, HössM, GunzD, et al. (1999) Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell, 3:33-42.
19.
LalleP, NouspikelT, ConstantinouA, et al. (2002) The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity. J Invest Dermatol, 118:344-351.
20.
LiC, YinM, WangLE, et al. (2013) Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol, 133:1813-1821.
21.
LiGM (2012) A special issue on DNA damage response and genome stability. Cell Biosci, 2:4.
22.
LindahlT (1993) Instability and decay of the primary structure of DNA. Nature, 362:709-715.
23.
MaH, YuH, LiuZ, et al. (2012) Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics, 22:50-57.
24.
MengX, WangQX, ChenMY, et al. (2013) DNA repair gene polymorphisms in ERCC4 rs6498486 and ERCC5 rs751402 and risk of salivary gland tumors. Shanghai Kou Qiang Yi Xue, 22:438-442.
25.
MillerSA, DykesDD, PoleskyHF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16:1215.
26.
ScherlyD, NouspikelT, CorletJ, et al. (1993) Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature, 363:182-185.
27.
SiewertJR, SteinHJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg, 85:1457-1459.
28.
TomlinsonI, WebbE, Carvajal-CarmonaL, et al. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet, 39:984-988.
29.
TranGD, SunXD, AbnetCC, et al. (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer, 113:456-463.
30.
WakasugiM, ReardonJT, et al. (1997) The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. J Biol Chem, 272:16030-16034.
31.
WangM, ZhangR, HeJ, et al. (2012) Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One, 7:e31932.
32.
WeiQ, ChengL, HongWK, et al. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res, 56:4103-4107.
33.
WenD, ShanB, WangS, et al. (2010) A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area. Eur J Med Genet, 53:250-255.
34.
XuP, ChenB, FengJ, et al. (2012) Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. Int J Hematol, 96:450-460.
35.
YeagerM, OrrN, HayesRB, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet, 39:645-649.
36.
YoonAJ, KuoWH, LinCW, et al. (2011) Role of ERCC5 polymorphism in risk of hepatocellular carcinoma. Oncol Lett, 2:911-914.
37.
ZavrasAI, YoonAJ, ChenMK, et al. (2012) Association between polymorphisms of DNA repair gene ERCC5 and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol, 114:624-629.
38.
ZhuML, ShiTY, HuHC, et al. (2012). Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations. PLoS One, 7:e41500.
